Gotowa bibliografia na temat „Vaccines”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Vaccines”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Vaccines"
Ricke, Darrell O. "Etiology model for many vaccination adverse reactions, including SARS-CoV-2 spike vaccines". AIMS Allergy and Immunology 6, nr 4 (2022): 200–215. http://dx.doi.org/10.3934/allergy.2022015.
Pełny tekst źródłaOkanlawon, A. A., S. A. Ameen, R. A. Kadir, H. M. Ambali, Y. A. Baba, O. M. Azeez i A. A. Owoade. "In vitro assessment of the potency of some Newcastle disease vaccine brands in Ibadan, Nigeria". African Journal of Clinical and Experimental Microbiology 21, nr 4 (25.08.2020): 328–32. http://dx.doi.org/10.4314/ajcem.v21i4.9.
Pełny tekst źródłaBroderick, Michael P., Sandra Romero-Steiner, Gowrisankar Rajam, Scott E. Johnson, Andrea Milton, Ellie Kim, Lisa J. Choi i in. "Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone". Clinical and Vaccine Immunology 23, nr 8 (8.06.2016): 672–80. http://dx.doi.org/10.1128/cvi.00267-16.
Pełny tekst źródłaTrombetta, Claudia Maria, Otfried Kistner, Emanuele Montomoli, Simonetta Viviani i Serena Marchi. "Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines". Vaccines 10, nr 5 (1.05.2022): 714. http://dx.doi.org/10.3390/vaccines10050714.
Pełny tekst źródłaYagovkin, E. A., G. G. Onishchenko, A. Yu Popova, E. B. Ezhlova, A. A. Melnikova, M. Yu Soloviev, E. V. Kovalev i in. "Condition and Prospects of Development of Vaccines for Specific Prevention of Enterovirus (Nonpolio) Infection". Epidemiology and Vaccine Prevention 15, nr 4 (20.08.2016): 74–82. http://dx.doi.org/10.31631/2073-3046-2016-15-4-74-82.
Pełny tekst źródłaLe, Ting, Chao Sun, Jitao Chang, Guijie Zhang i Xin Yin. "mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases". Viruses 14, nr 2 (15.02.2022): 401. http://dx.doi.org/10.3390/v14020401.
Pełny tekst źródłaCheng, Liqin, Yan Wang i Juan Du. "Human Papillomavirus Vaccines: An Updated Review". Vaccines 8, nr 3 (16.07.2020): 391. http://dx.doi.org/10.3390/vaccines8030391.
Pełny tekst źródłaChoi, Wongyeong, i Eunha Shim. "Vaccine Effects on Susceptibility and Symptomatology Can Change the Optimal Allocation of COVID-19 Vaccines: South Korea as an Example". Journal of Clinical Medicine 10, nr 13 (25.06.2021): 2813. http://dx.doi.org/10.3390/jcm10132813.
Pełny tekst źródłaNeri, Margherita, Simon Brassel i Lotte Steuten. "OP256 Recognising The Broader Value Of Vaccines In Health Technology Assessment: Worth A Shot?" International Journal of Technology Assessment in Health Care 37, S1 (grudzień 2021): 9–10. http://dx.doi.org/10.1017/s0266462321000878.
Pełny tekst źródłaMalik, Sumira, Shristi Kishore, Sagnik Nag, Archna Dhasmana, Subham Preetam, Oishi Mitra, Darwin A. León-Figueroa i in. "Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges". Vaccines 11, nr 2 (26.01.2023): 268. http://dx.doi.org/10.3390/vaccines11020268.
Pełny tekst źródłaRozprawy doktorskie na temat "Vaccines"
Farfan, Arribas Diego Jose. "DNA Vaccines Against HIV-1: Augmenting Immunogenicity of gp120". Link to electronic thesis, 2002. http://www.wpi.edu/Pubs/ETD/Available/etd-0107102-160706/.
Pełny tekst źródłaParker, Christopher S. "Effect of a codon optimized DNA prime on induction of anti-influenza protective antibodies". Worcester, Mass. : Worcester Polytechnic Institute, 2007. http://www.wpi.edu/Pubs/ETD/Available/etd-040907-100839/.
Pełny tekst źródłaSatti, Iman. "Immunogenicity of anti-leishmaniasis vaccines in man /". Stockholm, 2004. http://diss.kib.ki.se/2004/91-7349-779-7/.
Pełny tekst źródłaRainczuk, Adam 1976. "Evaluation of DNA vaccine targeting strategies and expression library immunisation against lethal erythrocytic stage Malaria". Monash University, Dept. of Biochemistry and Molecular Biology, 2003. http://arrow.monash.edu.au/hdl/1959.1/5685.
Pełny tekst źródłaGrubb, Kimberley L. "A genomic approach to the identification of novel malaria vaccine antigens /". Thesis, McGill University, 2005. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=98715.
Pełny tekst źródłaAtcheson, Erwan. "Prospects for enhancing malaria vaccine efficacy by combining pre-erythrocytic antigens". Thesis, University of Oxford, 2017. http://ora.ox.ac.uk/objects/uuid:6506c003-7065-4d48-b049-f5e9136443d5.
Pełny tekst źródłaHutchings, Claire L. "Combination vaccines". Thesis, University of Oxford, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.437038.
Pełny tekst źródłaSingh, Gagandeep. "RNA Viral Prophylaxis: Problems and Potential Solutions". Diss., North Dakota State University, 2019. https://hdl.handle.net/10365/29458.
Pełny tekst źródłaUnited States Department of Agriculture, National Institute of Food and Agriculture (USDA-NIFA)
North Dakota State Agricultural Products Utilization Committee (ND APUC)
North Dakota State Board of Agricultural Research (ND SABRE)
Khan, Tila. "Tailored influenza virus vaccines for both the young and old: Vaccine Efficacy of Whole Inactivated Vaccines bearing Immunomodulatory Adjuvants or Multimeric peptides". Diss., Virginia Tech, 2012. http://hdl.handle.net/10919/77130.
Pełny tekst źródłaPh. D.
Dannetun, Eva. "Reasons for non-vaccination /". Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-739-1/.
Pełny tekst źródłaKsiążki na temat "Vaccines"
1925-, Brown Fred, i Cold Spring Harbor Laboratory, red. Vaccines 90: Modern approaches to new vaccines including prevention of AIDS. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory Press, 1990.
Znajdź pełny tekst źródłaGregoriadis, Gregory, Anthony C. Allison i George Poste, red. Vaccines. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6.
Pełny tekst źródłaGregoriadis, Gregory, Brenda McCormack i Anthony C. Allison, red. Vaccines. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4613-0357-2.
Pełny tekst źródłaDomachowske, Joseph, i Manika Suryadevara, red. Vaccines. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-58414-6.
Pełny tekst źródłaPerlmann, Peter, i Hans Wigzell, red. Vaccines. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-59955-2.
Pełny tekst źródłaMisch, Kelly, Cathleen Dalton i William D. Martineau. Vaccines. Cleveland, Ohio: Freedonia Group, 2004.
Znajdź pełny tekst źródłaSylvia, Engdahl, red. Vaccines. Detroit: Greenhaven Press, 2009.
Znajdź pełny tekst źródła1932-, Plotkin Stanley A., i Orenstein Walter A, red. Vaccines. Wyd. 3. Philadelphia: W.B. Saunders Co., 1999.
Znajdź pełny tekst źródłaGoldstein, Natalie. Vaccines. New York, NY: Chelsea House, 2011.
Znajdź pełny tekst źródłaLaboratory, Cold Spring Harbor. Vaccines. Cold Spring Harbor, N.Y: Cold Spring Harbor Laboratory, 1985.
Znajdź pełny tekst źródłaCzęści książek na temat "Vaccines"
Wu, Chung-Yi, i Chi-Huey Wong. "Vaccines Vaccine". W Glycoscience: Biology and Medicine, 1529–36. Tokyo: Springer Japan, 2014. http://dx.doi.org/10.1007/978-4-431-54841-6_198.
Pełny tekst źródłaJain, Ananya, i Shilpa Sharma. "Nanotechnology in COVID-19 Vaccines". W Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022), 14–26. Dordrecht: Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-020-6_3.
Pełny tekst źródłaSmith, G. L. "Recombinant vaccinia virus vaccines". W Recent Developments in Prophylactic Immunization, 313–33. Dordrecht: Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-1067-6_15.
Pełny tekst źródłaSpithill, Terry W., Hayley Toet, Vignesh Rathinasamy, Gemma Zerna, Jaclyn Swan, Timothy Cameron, Peter M. Smooker, David M. Piedrafita, Robert Dempster i Travis Beddoe. "Vaccines for Fasciola: new thinking for an old problem." W Fasciolosis, 379–422. Wyd. 2. Wallingford: CABI, 2021. http://dx.doi.org/10.1079/9781789246162.0012.
Pełny tekst źródłaKnight, Stella C. "Dendritic Cells in the Induction of Immunity". W Vaccines, 1–6. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_1.
Pełny tekst źródłaOosterlaken, Tom A. M., Theo Harmsen, Cornelis A. Kraaijeveld i Harm Snippe. "Efficient Anti-Idiotypic Immunization with Homologous, Virus Neutralizing Monoclonal Antibodies Conjugated with KLH and Combined with Quil A". W Vaccines, 93–98. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_10.
Pełny tekst źródłaBartoloni, A., M. G. Pizza, A. Covacci, D. Nucci, L. Nencioni i R. Rappuoli. "Protein Conformation Affects the Efficacy of Pertussis Vaccines". W Vaccines, 99–105. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_11.
Pełny tekst źródłaEpstein, M. A. "Vaccination Against Epstein-Barr Virus". W Vaccines, 107–12. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_12.
Pełny tekst źródłaHsu, K.-H., M. Lubeck, S. Mizutani, R. Natuk, M. Chengalvala, P. Chanda, R. Bhat i in. "Adenovirus Vectored Vaccines". W Vaccines, 113–19. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_13.
Pełny tekst źródłaMakela, P. Helena, Helena Kayhty, Aino K. Takala, Heikki Peltola i Juhani Eskola. "Vaccines Against Bacterial Infections of Children". W Vaccines, 121–35. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3848-6_14.
Pełny tekst źródłaStreszczenia konferencji na temat "Vaccines"
Kumar, Vishnu, Vijay Srinivasan i Soundar Kumara. "Towards Smart Vaccine Manufacturing: A Preliminary Study During COVID-19". W ASME 2021 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2021. http://dx.doi.org/10.1115/imece2021-70516.
Pełny tekst źródłaTarabrin, R. E., i E. S. Pyatigorec. "BIOETHICAL ISSUES OF VACCINOMICS". W I International Congress “The Latest Achievements of Medicine, Healthcare, and Health-Saving Technologies”. Kemerovo State University, 2023. http://dx.doi.org/10.21603/-i-ic-130.
Pełny tekst źródłaZughaier, Susu. "High Vaccine Coverage is Crucial for Preventing the Spread of Infectious Diseases During Mass Gathering". W Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0138.
Pełny tekst źródłaBularca, Maria Cristina, Claudiu Coman, Luiza Mesesan Schmitz, Doina Draguinea i Radu Tudorica. "THE ROLE OF ONLINE MEDIA CHANNELS IN PORTRAYING THE EFFECTS OF THE COVID-19 VACCINE". W 9th SWS International Scientific Conferences on SOCIAL SCIENCES - ISCSS 2022. SGEM WORLD SCIENCE, 2022. http://dx.doi.org/10.35603/sws.iscss.2022/s10.100.
Pełny tekst źródłaKrishnakumar, D., i K. S. Jaganathan. "Development of nasal HPV vaccine formulations". W 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685403.
Pełny tekst źródłaCamargo, Luana Cristina, Joao Paulo Figueiro Longo, Karen Letycia Rodrigues de Paiva, Marina Mesquita Simões, Thais Bergmann i Victor Carlos Mello da Silva. "Immunotherapy vaccines for triple-negative breast cancer and its influence on the tumor microenvironment". W Brazilian Breast Cancer Symposium 2023. Mastology, 2023. http://dx.doi.org/10.29289/259453942023v33s1024.
Pełny tekst źródła"What factors are related to practicing COVID-19 vaccine by population at Ghawr Al-Safi, Jordan". W International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/yrrz1540.
Pełny tekst źródłaZhu, Richard, i Sujata Bhatia. "Optimizing COVID-19 Vaccine Diffusion in Respiratory Mucosa through Stokes-Einstein Modeling". W 2022 Design of Medical Devices Conference. American Society of Mechanical Engineers, 2022. http://dx.doi.org/10.1115/dmd2022-1065.
Pełny tekst źródłaGIRARD, MARC. "CANCER VACCINES". W International Seminar on Nuclear War and Planetary Emergencies 38th Session. WORLD SCIENTIFIC, 2008. http://dx.doi.org/10.1142/9789812834645_0041.
Pełny tekst źródłaSun, Jianping. "Identifying Safety-Vaccine Association for COVID-19 Vaccines from VAERS". W 4th International Conference on Statistics: Theory and Applications (ICSTA'22). Avestia Publishing, 2022. http://dx.doi.org/10.11159/icsta22.148.
Pełny tekst źródłaRaporty organizacyjne na temat "Vaccines"
Ennis, Francis A., i Walter E. Demkowicz. Human Immune Responses to Experimental Vaccinia Vaccines. Fort Belvoir, VA: Defense Technical Information Center, lipiec 1995. http://dx.doi.org/10.21236/ada299784.
Pełny tekst źródłaByrn, Stephen, Nathaniel Milton i Kari Clase. BIRS Course: RNA Vaccine Manufacture and Assessment of Regulatory Documents for RNA Vaccines. Purdue University, sierpień 2023. http://dx.doi.org/10.5703/1288284317657.
Pełny tekst źródłaGidengil, Courtney, Matthew Bidwell Goetz, Margaret Maglione, Sydne J. Newberry, Peggy Chen, Kelsey O’Hollaren, Nabeel Qureshi i in. Safety of Vaccines Used for Routine Immunization in the United States: An Update. Agency for Healthcare Research and Quality (AHRQ), maj 2021. http://dx.doi.org/10.23970/ahrqepccer244.
Pełny tekst źródłaKorber, Bette T. M. Talk: Why Vaccines? Office of Scientific and Technical Information (OSTI), kwiecień 2014. http://dx.doi.org/10.2172/1129055.
Pełny tekst źródłaRoldan de Jong, Tamara. Rapid Review: Perceptions of COVID-19 Vaccines in South Africa. SSHAP, kwiecień 2022. http://dx.doi.org/10.19088/sshap.2021.021.
Pełny tekst źródłaPilon, Shari. Recombinant Breast Cancer Vaccines. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 1999. http://dx.doi.org/10.21236/ada384110.
Pełny tekst źródłaMitchell, Renae. Vaccines: Then and Now. Office of Scientific and Technical Information (OSTI), marzec 2022. http://dx.doi.org/10.2172/1859873.
Pełny tekst źródłaButler, Nadia, i Soha Karam. Evidence Review: COVID-19 Vaccine Acceptance by Key Influencers in the MENA Region - Teachers and Healthworkers. Institute of Development Studies (IDS), listopad 2021. http://dx.doi.org/10.19088/sshap.2021.039.
Pełny tekst źródłaVallerani, Sara, Elizabeth Storer i Costanza Torre. Key Considerations: Equitable Engagement to Promote COVID-19 Vaccine Uptake among Undocumented Urban Migrants. SSHAP, maj 2022. http://dx.doi.org/10.19088/sshap.2022.013.
Pełny tekst źródłaTull, Kerina. Social Inclusion and Immunisation. Institute of Development Studies (IDS), luty 2021. http://dx.doi.org/10.19088/k4d.2021.025.
Pełny tekst źródła